THIS INFORMATION IS ONLY FOR PATIENTS WHO HAVE BEEN PRESCRIBED THE ABOVE AUTO-INJECTORS
The Medicines and Healthcare products Regulatory Agency (MHRA) is aware of a safety issue, potentially impacting all Emerade 500 micrograms and Emerade 300 micrograms auto-injectors (also referred to as pens). The issue may mean that pens fail to activate and deliver adrenaline if they have been dropped. Premature activation was also detected in one Emerade pen after it had been dropped, meaning that the adrenaline solution may be released prior to administration. As a precautionary measure and due to the inability to identify this error before the auto-injector is used, the autoinjectors are being recalled.
If you have been given Emerade pens, continue to use them as instructed until they are replaced. If your first Emerade pen does not activate despite firm pressure, immediately use your second pen. Always carry two adrenaline pens with you and use them if you need to.
If you still require use of adrenaline auto-injectors and need to replace your Emerade pens:
- please ring the prescription line to request a new prescription to replace each Emerade auto-injector – 01457935345
- once you have a replacement, you should return your Emerade auto-injectors to any pharmacy
- contact the surgery directly if you are worried